CytoVista

Private

Portland, OregonHealthcare & Life Scienceshttps://www.cyto-vista.com/

Company Overview

CytoVista operates in Healthcare & Life Sciences and is based in Portland, Oregon. It was founded in 2026.

CytoVista is a biotechnology company that develops intelligent AI platforms for hematopathology to improve diagnostic workflows.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CytoVista Comparables

Compare CytoVista with similar companies based on industry and business-model similarity.

CytoVista comparables — related companies by embedding similarity
Company	Similarity	Market Cap
AltraBio	78%	Demo
Neomend	75%	Demo
Siemens	74%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

CytoVista Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for CytoVista. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

CytoVista Filings

Explore SEC and related filing metadata, where available.

CytoVista filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CytoVista's valuation, stock price, and market status.

Is CytoVista a public or private company?

CytoVista is a private company.

What is the current stock price of CytoVista?

CytoVista is a private company, so its shares have no public market price. Caplight tracks CytoVista's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CytoVista worth (valuation)?

Valuation information for CytoVista is not publicly available.

Can I buy CytoVista stock?

CytoVista shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CytoVista's last funding round?

Funding round information for CytoVista is not publicly available.

Who are the main investors in CytoVista?

Investor information for CytoVista is not publicly disclosed.

Will CytoVista IPO soon?

No public IPO plans have been announced for CytoVista.

How can I track CytoVista secondary market activity?

Caplight tracks bids, offers, and trades in CytoVista's shares on secondary markets.

Firmographic Details

HeadquartersPortland, Oregon

Year Founded2026

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?